Publications:

---

Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology

Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR

Publication Date: 2019-04

Variant appearance in text: TP53: P142R

PubMed Link: 31034466

Variant Present in the following documents:

• pcbi.1006981.s010.xlsx, sheet 1

View BVdb publication page

---

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status.

Leukemia

Kubesova, B B; Pavlova, S S; Malcikova, J J; Kabathova, J J; Radova, L L; Tom, N N; Tichy, B B; Plevova, K K; Kantorova, B B; Fiedorova, K K; Slavikova, M M; Bystry, V V; Kissova, J J; Gisslinger, B B; Gisslinger, H H; Penka, M M; Mayer, J J; Kralovics, R R; Pospisilova, S S; Doubek, M M

Publication Date: 2018-02

Variant appearance in text: TP53: P142R

PubMed Link: 28744014

Variant Present in the following documents:

• Main text
• leu2017230x2.xlsx, sheet 1
• leu2017230x3.xlsx, sheet 1
• leu2017230a.pdf

View BVdb publication page

---

iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.

Scientific Reports

Wang, Meng M; Wei, Liping L

Publication Date: 2016-08-16

Variant appearance in text: TP53: P142R

PubMed Link: 27527004

Variant Present in the following documents:

• srep31321-s5.xls, sheet 1

View BVdb publication page

---

GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics

Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J

Publication Date: 2015-07-25

Variant appearance in text: TP53: P142R

PubMed Link: 26206375

Variant Present in the following documents:

• 12859_2015_673_MOESM1_ESM.xls, sheet 1

View BVdb publication page

---

CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.

Plos Medicine

Martinez-Torres, Ana-Carolina AC; Quiney, Claire C; Attout, Tarik T; Boullet, Heloïse H; Herbi, Linda L; Vela, Laura L; Barbier, Sandrine S; Chateau, Danielle D; Chapiro, Elise E; Nguyen-Khac, Florence F; Davi, Frédéric F; Le Garff-Tavernier, Magali M; Moumné, Roba R; Sarfati, Marika M; Karoyan, Philippe P; Merle-Béral, Hélène H; Launay, Pierre P; Susin, Santos A SA

Publication Date: 2015-03

Variant appearance in text: TP53: 425C>G

PubMed Link: 25734483

Variant Present in the following documents:

• Main text
• pmed.1001796.pdf

View BVdb publication page

---

Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.

Genome Biology

Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B

Publication Date: 2014-10-28

Variant appearance in text: TP53: P142R

PubMed Link: 25348012

Variant Present in the following documents:

• 13059_2014_484_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

The Tanapoxvirus 142R Protein is a Serine-Threonine Kinase that Phosphorylates the Tumor Suppressor p53.

The Open Virology Journal

Seibert, Krystal N KN; Essani, Karim K; Bejcek, Bruce E BE

Publication Date: 2013

Variant appearance in text: p53: p142R

PubMed Link: 23359106

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Functional assessment of p53 in chronic lymphocytic leukemia.

Blood Cancer Journal

Le Garff-Tavernier, M M; Blons, H H; Nguyen-Khac, F F; Pannetier, M M; Brissard, M M; Gueguen, S S; Jacob, F F; Ysebaert, L L; Susin, S A SA; Merle-Béral, H H

Publication Date: 2011-02

Variant appearance in text: TP53: P142R

PubMed Link: 22829111

Variant Present in the following documents:

• Main text
• bcj20113a.pdf

View BVdb publication page

---